Effect of manual and digital contact tracing on COVID-19 outbreaks: a study on empirical contact data.


Journal

Journal of the Royal Society, Interface
ISSN: 1742-5662
Titre abrégé: J R Soc Interface
Pays: England
ID NLM: 101217269

Informations de publication

Date de publication:
May 2021
Historique:
entrez: 5 5 2021
pubmed: 6 5 2021
medline: 22 6 2021
Statut: ppublish

Résumé

Non-pharmaceutical interventions are crucial to mitigate the COVID-19 pandemic and contain re-emergence phenomena. Targeted measures such as case isolation and contact tracing can alleviate the societal cost of lock-downs by containing the spread where and when it occurs. To assess the relative and combined impact of manual contact tracing (MCT) and digital (app-based) contact tracing, we feed a compartmental model for COVID-19 with high-resolution datasets describing contacts between individuals in several contexts. We show that the benefit (epidemic size reduction) is generically linear in the fraction of contacts recalled during MCT and quadratic in the app adoption, with no threshold effect. The cost (number of quarantines) versus benefit curve has a characteristic parabolic shape, independent of the type of tracing, with a potentially high benefit and low cost if app adoption and MCT efficiency are high enough. Benefits are higher and the cost lower if the epidemic reproductive number is lower, showing the importance of combining tracing with additional mitigation measures. The observed phenomenology is qualitatively robust across datasets and parameters. We moreover obtain analytically similar results on simplified models.

Identifiants

pubmed: 33947224
doi: 10.1098/rsif.2020.1000
pmc: PMC8097511
doi:

Banques de données

figshare
['10.6084/m9.figshare. c.5401758']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

20201000

Références

BMC Med. 2020 Jul 30;18(1):240
pubmed: 32727547
Phys Rev E Stat Nonlin Soft Matter Phys. 2002 Jul;66(1 Pt 2):016128
pubmed: 12241447
Lancet Glob Health. 2020 Apr;8(4):e488-e496
pubmed: 32119825
Science. 2020 May 8;368(6491):
pubmed: 32234805
Proc Natl Acad Sci U S A. 2016 Sep 6;113(36):9977-82
pubmed: 27555584
Nature. 2020 Aug;584(7820):262-267
pubmed: 32512578
PLoS One. 2010 Jul 15;5(7):e11596
pubmed: 20657651
Science. 2020 Jul 10;369(6500):208-211
pubmed: 32404476
Sci Data. 2019 Dec 11;6(1):315
pubmed: 31827097
Sci Adv. 2021 Apr 9;7(15):
pubmed: 33712416
PLoS One. 2014 Apr 25;9(4):e95978
pubmed: 24770359
Lancet Infect Dis. 2020 Oct;20(10):1151-1160
pubmed: 32559451
Swiss Med Wkly. 2020 Dec 16;150:w20457
pubmed: 33327003
Euro Surveill. 2020 Apr;25(17):
pubmed: 32372755
Lancet Infect Dis. 2020 Jun;20(6):678-688
pubmed: 32213332
PLoS One. 2015 Sep 01;10(9):e0136497
pubmed: 26325289
PLoS One. 2014 Jul 07;9(7):e100915
pubmed: 24999984
Nat Commun. 2021 Jan 11;12(1):232
pubmed: 33431829
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
pubmed: 15071187
Science. 2020 Jun 26;368(6498):1481-1486
pubmed: 32350060
Lancet Public Health. 2020 Aug;5(8):e452-e459
pubmed: 32682487
Phys Rev E. 2018 Jun;97(6-1):062312
pubmed: 30011557
BMC Med. 2011 Jul 19;9:87
pubmed: 21771290
BMC Infect Dis. 2013 Apr 23;13:185
pubmed: 23618005
JAMA Intern Med. 2020 Sep 1;180(9):1156-1163
pubmed: 32356867
PLoS One. 2014 Jan 31;9(1):e86028
pubmed: 24497935
Nat Commun. 2021 Mar 12;12(1):1655
pubmed: 33712583
PLoS Med. 2020 Jul 17;17(7):e1003193
pubmed: 32678827
J R Soc Interface. 2010 Sep 6;7(50):1247-56
pubmed: 20504800
Nat Med. 2021 Mar;27(3):361-362
pubmed: 33589822
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Nat Commun. 2015 Nov 13;6:8860
pubmed: 26563418
J R Soc Interface. 2018 Jan;15(138):
pubmed: 29298957
PLoS One. 2006 Dec 20;1:e12
pubmed: 17183638
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404

Auteurs

A Barrat (A)

Aix Marseille Univ., CNRS, CPT, Turing Center for Living Systems, Université de Toulon, Marseille, France.
Tokyo Tech World Research Hub Initiative (WRHI), Tokyo Institute of Technology, Tokyo, Japan.

C Cattuto (C)

Computer Science Department, University of Turin, Turin, Italy.
ISI Foundation, Turin, Italy.

M Kivelä (M)

Department of Computer Science, Aalto University, Aalto, Finland.

S Lehmann (S)

Technical University of Denmark, Copenhagen, Denmark.

J Saramäki (J)

Department of Computer Science, Aalto University, Aalto, Finland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH